Ningbo David Medical Device Co., Ltd.
SZSE:300314.SZ
12.63 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 618.298 | 506.037 | 474.133 | 459.531 | 356.352 | 300.298 | 303.905 | 264.949 | 219.427 | 227.181 | 217.245 | 255.79 | 206.741 | 177.691 | 149.79 | 140.407 |
| Cost of Revenue
| 258.478 | 209.74 | 182.202 | 190.077 | 164.745 | 148.054 | 147.564 | 123.864 | 103.515 | 105.641 | 98.597 | 109.807 | 89.83 | 81.437 | 72.373 | 77.914 |
| Gross Profit
| 359.82 | 296.297 | 291.931 | 269.453 | 191.607 | 152.244 | 156.342 | 141.085 | 115.912 | 121.54 | 118.648 | 145.983 | 116.911 | 96.254 | 77.417 | 62.493 |
| Gross Profit Ratio
| 0.582 | 0.586 | 0.616 | 0.586 | 0.538 | 0.507 | 0.514 | 0.532 | 0.528 | 0.535 | 0.546 | 0.571 | 0.565 | 0.542 | 0.517 | 0.445 |
| Reseach & Development Expenses
| 48.059 | 45.869 | 49.694 | 40.223 | 40.328 | 28.254 | 18.013 | 14.679 | 13.997 | 13.714 | 9.971 | 9.455 | 8.891 | 8.388 | 7.495 | 5.477 |
| General & Administrative Expenses
| 16.864 | 13.602 | 13.496 | 13.824 | 11.381 | 10.983 | 7.572 | 6.544 | 7.373 | 5.737 | 4.605 | 6.789 | 8.184 | 8.119 | 8.667 | 6.847 |
| Selling & Marketing Expenses
| 121.92 | 111.567 | 121.662 | 84.147 | 63.301 | 50.769 | 43.407 | 34.646 | 27.777 | 25.794 | 20.971 | 25.441 | 15.26 | 14.653 | 14.205 | 12.423 |
| SG&A
| 138.784 | 125.17 | 135.158 | 97.971 | 74.682 | 61.753 | 50.979 | 41.19 | 35.149 | 31.531 | 25.576 | 32.23 | 23.444 | 22.772 | 22.872 | 19.27 |
| Other Expenses
| -5.14 | 28.459 | 33.822 | 29.36 | 21.466 | -2.5 | -1.607 | 3.783 | 1.105 | 0.424 | 1.228 | 1.692 | 0.91 | 3.305 | 3.383 | 1.303 |
| Operating Expenses
| 216.601 | 199.498 | 218.675 | 167.555 | 136.476 | 107.573 | 94.289 | 78.868 | 70.749 | 67.003 | 55.953 | 62.284 | 49.54 | 46.355 | 42.214 | 32.907 |
| Operating Income
| 171.365 | 112.01 | 87.227 | 147.802 | 72.009 | 42.398 | 60.459 | 70.183 | 52.834 | 63.621 | 74.089 | 85.477 | 62.723 | 44.178 | 30.882 | 27.714 |
| Operating Income Ratio
| 0.277 | 0.221 | 0.184 | 0.322 | 0.202 | 0.141 | 0.199 | 0.265 | 0.241 | 0.28 | 0.341 | 0.334 | 0.303 | 0.249 | 0.206 | 0.197 |
| Total Other Income Expenses Net
| -5.14 | -0.094 | -0.034 | -1.149 | -2.205 | -4.773 | -3.2 | 11.595 | 8.751 | 9.488 | 12.606 | 3.426 | -3.928 | -4.512 | -1.077 | -0.57 |
| Income Before Tax
| 166.225 | 111.916 | 87.193 | 146.652 | 69.804 | 39.898 | 58.852 | 73.812 | 53.914 | 64.025 | 75.301 | 87.125 | 63.443 | 45.386 | 34.127 | 29.016 |
| Income Before Tax Ratio
| 0.269 | 0.221 | 0.184 | 0.319 | 0.196 | 0.133 | 0.194 | 0.279 | 0.246 | 0.282 | 0.347 | 0.341 | 0.307 | 0.255 | 0.228 | 0.207 |
| Income Tax Expense
| 18.614 | 14.338 | 6.986 | 10.462 | 7.747 | 11.085 | 11.819 | 11.646 | 8.979 | 10.418 | 11.229 | 13.258 | 9.474 | 6.795 | 5.169 | 4.209 |
| Net Income
| 147.611 | 97.359 | 80.207 | 136.19 | 62.057 | 28.813 | 47.033 | 62.166 | 44.934 | 53.607 | 64.072 | 73.867 | 53.969 | 38.592 | 28.957 | 24.807 |
| Net Income Ratio
| 0.239 | 0.192 | 0.169 | 0.296 | 0.174 | 0.096 | 0.155 | 0.235 | 0.205 | 0.236 | 0.295 | 0.289 | 0.261 | 0.217 | 0.193 | 0.177 |
| EPS
| 0.51 | 0.34 | 0.28 | 0.47 | 0.22 | 0.1 | 0.16 | 0.22 | 0.16 | 0.19 | 0.22 | 0.28 | 0.25 | 0.18 | 0.13 | 0.11 |
| EPS Diluted
| 0.51 | 0.34 | 0.28 | 0.47 | 0.22 | 0.1 | 0.16 | 0.22 | 0.16 | 0.19 | 0.22 | 0.28 | 0.25 | 0.18 | 0.13 | 0.11 |
| EBITDA
| 197.271 | 138.597 | 113.572 | 168.079 | 79.958 | 85.576 | 87.108 | 74.382 | 55.086 | 64.051 | 83.912 | 98.075 | 76.962 | 61.586 | 44.247 | 34.986 |
| EBITDA Ratio
| 0.319 | 0.274 | 0.24 | 0.366 | 0.224 | 0.285 | 0.287 | 0.281 | 0.251 | 0.282 | 0.386 | 0.383 | 0.372 | 0.347 | 0.295 | 0.249 |